Treating DED starts with MGD
Thank you for requesting a call about the TearCare® System.
One of our TearCare® representatives will contact you within 3 to 5 business days.
Indications for Use: The TearCare® System is intended for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD), when used in conjunction with manual expression of the meibomian glands.
The TearCare® System may not be right for everyone. Please see Instructions for Use or visit TearCare.com for Contraindications, Warnings, Precautions and Adverse Events.
TearCare®, SmartLids®, and SmartHub® are registered trademarks of Sight Sciences. Clearance Assistant™ is a trademark of Sight Sciences and for use only by Sight Sciences.
© 2023 Sight Sciences, Inc. 1/23 TC-xxxx-US.v1